Install
Latest news coverage, email, free stock quotes, live scores and video are just the beginning. Discover more every day at Yahoo!
- 32,998articles · 30d
- 1+ hour agolatest article
- Aug 15, 2026earliest in window
- 93%with images
- 185avg words
- local news 14,078
- local 7,499
- politics 6,342
- entertainment 5,325
- world 5,068
- video 4,733
- local-news 4,543
- donald trump 3,972
- world news 3,772
- crime 3,706
- lifestyle 3,647
- business 3,638
- us 3,138
- u.s. 3,127
- mc complete - state & national 2,905
- newsbreak 2,768
- weather 2,378
- health 2,223
- homepage 2,186
- htv-video-syndication 1,991
- Sensitive Subjects 7,392
- News 7,233
- Politics 6,761
- Entertainment 6,210
- Crime & Law 5,788
- Arts & Entertainment 4,672
- Politics2 4,500
- Crime, Law & Justice 4,267
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough
2+ week, 2+ day ago (1038+ words) By Michael Erman and Julie Steenhuysen Aug 28 (Reuters) - Stephane Bancel, CEO of Moderna, was at a Lebanese restaurant celebrating a friend's birthday late on August 13 when he got the call. An mRNA cancer vaccine the company had been developing with…...
FDA approves updated COVID vaccine for seniors and high-risk adults
2+ week, 2+ day ago (116+ words) The U.S. Food and Drug Administration has approved an updated COVID-19 vaccine, with the latest shots expected to begin arriving at pharmacies and doctors' offices in September. The updated mRNA vaccine from Pfizer and BioNTech is approved for adults age 65 and…...
Explainer-How the Merck/Moderna cancer vaccine works and possible barriers to wide use
2+ week, 5+ day ago (579+ words) By Mariam Sunny and Christy Santhosh Aug 25 (Reuters) - The personalized cancer vaccine being developed by Moderna and Merck has boosted hopes that mRNA technology could open up a new avenue of treatment, but the available evidence is still limited. Interim…...
Moderna’s cancer vaccine clears phase 3; Ultragenyx lands gene therapy nod
3+ week, 3+ day ago (359+ words) Moderna and Merck's personalized mRNA cancer vaccine has passed its biggest test yet. The partners said Wednesday that intismeran autogene, paired with Keytruda, met both primary endpoints in a phase 3 melanoma study — the first positive phase 3 result for an mRNA…...
Moderna, Merck See Promise in Experimental Skin Cancer Vaccine
3+ week, 3+ day ago (10+ words) Yahoo...
Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma
3+ week, 4+ day ago (30+ words) Pharmaceutical giants Moderna and Merck said that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients. NBC News......
How Moderna's melanoma mRNA vaccine could fight deadliest skin cancer
3+ week, 4+ day ago (429+ words) Moderna is touting a "landmark moment" in its experimental melanoma treatment, saying its vaccine could help prevent the deadly skin cancer from returning or spreading. The groundbreaking clinical trial studied over 1,100 people whose melanoma was in advanced stages, taking a…...
How a new experimental cancer vaccine works: ‘A big deal’ | Elizabeth Vargas Reports
3+ week, 4+ day ago (50+ words) Yahoo Moderna and Merck announced this week that an experimental vaccine for melanoma patients showed positive initial results. Dr. Mahsa Tehrani joins "Elizabeth Vargas Reports" to explain the mRNA technology behind the potential breakthrough.#Health #Cancer #mRNA...
Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers
3+ week, 4+ day ago (242+ words) Pharmaceutical companies Moderna and Merck announced today the highly promising results of their anti-cancer mRNA vaccine Phase 3 clinical trial targeting later-stage melanoma skin cancers. Researchers sequenced the DNA from each patient's tumors to create personalized vaccines that, when injected, rev…...